Form 8-K - Current report:
SEC Accession No. 0001193125-20-104858
Filing Date
2020-04-13
Accepted
2020-04-13 08:31:03
Documents
3
Period of Report
2020-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912211d8k.htm 8-K 34531
2 EX-4.1 d912211dex41.htm EX-4.1 57263
3 EX-10.1 d912211dex101.htm EX-10.1 374684
  Complete submission text file 0001193125-20-104858.txt   467797
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 20787863
SIC: 2834 Pharmaceutical Preparations